Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$410 Sell
3
-2
-40% -$246 ﹤0.01% 949
2026
Q1
$590 Buy
+5
New +$698 ﹤0.01% 1019
2025
Q2
Sell
-21
Closed -$2.67K 1177
2025
Q1
$2.67K Buy
21
+4
+24% +$616 ﹤0.01% 712
2024
Q4
$2.45K Buy
17
+4
+31% +$574 ﹤0.01% 770
2024
Q3
$1.94K Hold
13
﹤0.01% 884
2024
Q2
$2.09K Buy
13
+4
+44% +$627 ﹤0.01% 816
2024
Q1
$1.62K Hold
9
﹤0.01% 782
2023
Q4
$1.62K Buy
+9
New +$1.4K ﹤0.01% 782

Other funds holding RGEN

Sachetta's RGEN Position: Q2 2026 in Review

Sachetta reduced its Repligen (RGEN) stake by 40% in Q2 2026, selling an estimated $246 and leaving 3 shares worth $410. The position accounts for ﹤0.01% of the portfolio, ranked #949.

Sachetta first reported a position in RGEN in Q4 2023 and has held it in 8 quarters since. The position peaked at $2.67K in Q1 2025. 48 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Sachetta held 3 shares of Repligen worth $410 as of Q2 2026.
  • Sachetta sold 2 Repligen shares in Q2 2026, an estimated $246.
  • Repligen made up ﹤0.01% of Sachetta's portfolio in Q2 2026, its #949 holding.
  • Sachetta first reported a position in Repligen in Q4 2023 and has held it in 8 quarters since.
  • Sachetta's Repligen position peaked at $2.67K in Q1 2025.
  • 48 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.